Hudson Bay Capital Management
NNVC icon

Hudson Bay Capital Management’s NanoViricides NNVC Stock Holding History

Hudson Bay Capital Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50,000
Closed -$287K – 535
2020
Q1 		$287K Buy
+50,000
New +$353K 0.01% 392
2019
Q2 		– Sell
-68,196
Closed -$368K – 632
2019
Q1 		$368K Buy
+68,196
New +$445K ﹤0.01% 624

Other funds holding NNVC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudson Bay Capital Management's NNVC Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of NanoViricides (NNVC) in Q2 2020, closing a stake of 50,000 shares — an estimated $287K sold.

Hudson Bay Capital Management first reported a position in NNVC in Q1 2019 and held it in 2 quarters. The position peaked at $368K in Q1 2019. 26 funds tracked by Wall St. Rank hold NNVC as of Q2 2020.

  • Hudson Bay Capital Management reported no remaining NanoViricides position as of Q2 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 50,000 NanoViricides shares in Q2 2020, an estimated $287K.
  • Hudson Bay Capital Management first reported a position in NanoViricides in Q1 2019 and held it in 2 quarters.
  • Hudson Bay Capital Management's NanoViricides position peaked at $368K in Q1 2019.
  • 26 funds tracked by Wall St. Rank held NanoViricides as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.